Director, Global Patient Strategy & Market Development, Migraine

Job description

Title: Director, Global Patient Strategy & Market Development, Migraine Company: Ipsen Biopharmaceuticals Inc. About Ipsen: Ipsen is a mid-sized global biopharmaceutical company with a focus on transformative medicines in three therapeutic areas: Oncology, Rare Disease and Neuroscience. Supported by nearly 100 years of development experience, with global hubs in the U.S., France and the U.K, we tackle areas of high unmet medical need through research and innovation. Our passionate teams in more than 40 countries are focused on what matters and endeavor every day to bring medicines to patients in 88 countries. We build a workplace that champions human-centric leadership and fosters a culture of collaboration, excellence and impact. At Ipsen, every individual is empowered to be their true selves, grow and thrive alongside the company’s success. Join us on our journey towards sustainable growth, creating real impact on patients and society! For more information, visit us at https://www.ipsen.com/ and follow our latest news on LinkedIn and Instagram. Job Description: The Director, Global Patient Strategy & Market Development, Migraine is responsible for defining and leading the global patient strategy and market-development agenda for Dysport in migraine. The role will develop a deep understanding of the migraine patient’s experience and identify the structural, behavioral and perceptual barriers that prevent appropriate patients from recognizing their disease burden, seeking care, receiving an accurate diagnosis, reaching appropriate specialist care and progressing toward effective preventive treatment. The Director will translate patient insights into strategies supporting market development, disease awareness, patient activation, patient experience and appropriate treatment consideration across chronic and episodic migraine. The Director will champion the use of advanced analytics, machine learning, artificial intelligence and other emerging technologies to deepen patient understanding, identify unmet market opportunities, improve segmentation and support more precise, scalable and insight-led patient and market-specific development strategies. The position will play a critical role in expanding addressable opportunities by identifying where patients are lost across their journey and developing scalable global strategies that markets can use to address these gaps. The role will work closely with Global Medical, Market Access, Insights & Analytics, GPPS, Corporate Affairs, the global and US organization and external agencies to ensure patient and market-development strategies are insight-led, innovative, globally scalable and locally relevant. WHAT - Main Responsibilities Global Patient Strategy • Lead development and evolution of the global patient strategy for Dysport in migraine across chronic and episodic migraine. • Develop a deep understanding of patient needs, beliefs, motivations, treatment expectations and barriers. • Define meaningful global patient segments based on needs, behaviors, disease burden, treatment history and readiness for preventive treatment. • Establish clear patient behavioral objectives aligned with the broader migraine commercial strategy. • Develop the global patient value proposition, messaging framework and patient-engagement principles. • Ensure advanced analytics and emerging technologies are appropriately incorporated into patient strategy where they can improve understanding, prioritization and decision-making. Patient Journey • Develop a comprehensive understanding of the patient journey, focused specifically on the patient audience and spanning symptom recognition, disease awareness, care seeking, diagnosis, referral, preventive-treatment consideration, treatment initiation and persistence. • Identify key patient drop-off points, unmet needs and barriers across that journey. • Understand how patient beliefs, knowledge, previous treatment experience, expectations and healthcare-system factors influence progression through the patient journey. • Identify opportunities to improve patient recognition of migraine burden and understanding of preventive-treatment options. • Apply patient-flow analytics and other advanced analytical approaches, where appropriate, to identify patterns, barriers and opportunities across the patient journey. • Ensure that patient journey strategy remains clearly focused on patient needs and behaviors, while collaborating with other functions on healthcare-system or HCP-dependent barriers. Market Development & Market Shaping • Develop global market-development strategies aimed at increasing the number of appropriate patients reaching effective preventive migraine treatment. • Identify structural barriers to market development, including underdiagnosis, undertreatment, delayed care seeking, delayed referral, limited disease awareness and inconsistent use of preventive therapy. • Identify opportunities to support appropriate evolution of the preventive-migraine treatment market across chronic and episodic migraine. • Define strategies to improve patient activation and support appropriate dialogue between patients and healthcare professionals. • Identify scalable opportunities to address patient-related barriers to diagnosis, referral and preventive-treatment consideration. • Partner with markets to prioritize market-development opportunities based on local epidemiology, healthcare-system dynamics, treatment pathways and patient behaviors. • Leverage advanced analytics, predictive approaches and other emerging capabilities to support identification and prioritization of high-value market-development opportunities. Patient Engagement & Activation • Define how education, disease awareness, patient activation and support can positively influence relevant patient behaviors. • Develop global patient-engagement principles that can be appropriately adapted to different regulatory and cultural environments. • Partner with Digital and other relevant functions to identify patient engagement opportunities and appropriate channels. • Explore the appropriate use of machine learning, AI-enabled analytics and other emerging technologies to improve the relevance, precision and effectiveness of patient engagement and activation strategies. • Partner with Digital, Data Science and analytics teams to identify opportunities for more tailored engagement based on patient needs, behaviors and journey stage. • Ensure patient communications are grounded in meaningful patient insights and deliver relevant, understandable and actionable information. • Ensure all data-driven and technology-enabled patient strategies are developed within applicable regulatory, privacy, legal and compliance requirements. Advocacy & External Engagement • Partner with Advocacy, Medical and other relevant functions to understand the perspectives and unmet needs of the migraine community. • Identify appropriate opportunities for disease awareness, patient education and community engagement. • Support strategic engagement with patient organizations and other relevant external stakeholders in compliance with applicable policies and regulations. • Incorporate patient and community insights into broader market-development and patient-engagement strategies. Global Launch & Market Collaboration • Partner with Regional and Local teams to develop global-to-local patient and market-development frameworks. • Ensure patient strategy is integrated with overall brand strategy, HCP strategy and launch planning while maintaining clear ownership of the patient audience and patient journey. • Work closely with priority markets to pressure-test global patient strategies and identify opportunities for scalable execution. • Partner with the US organization while ensuring global patient strategies remain applicable across diverse healthcare systems and regulatory environments. • Identify opportunities to pilot and scale innovative patient- and data-dri